Skip to main content
RemeGen Co., Ltd. logo

RemeGen Co., Ltd. — Investor Relations & Filings

Ticker · 9995 ISIN · CNE1000048G6 LEI · 300300M9HCX4TFAD4I10 HKEX Manufacturing
Open in API
Filings indexed 1,624 across all filing types
Latest filing 2025-04-02 Declaration of Voting R…
Country CN China
Listing HKEX 9995

About RemeGen Co., Ltd.

http://www.remegen.com

RemeGen Co., Ltd. is a biopharmaceutical company dedicated to the discovery, development, production, and commercialization of innovative biological drugs. The company focuses on creating first-in-class and best-in-class therapeutics to address significant unmet clinical needs, particularly in the critical therapeutic areas of autoimmune diseases, oncology, and ophthalmology. RemeGen utilizes proprietary technology platforms capable of discovering, screening, and developing new molecules and efficiently optimizing production processes. Its pipeline includes a series of innovative biologics, such as Telitacicept, and features 8 clinical pipelines, over 40 clinical trials, and more than 600 patent applications, demonstrating a strong commitment to R&D and innovation in biopharmaceuticals.

Recent filings

Filing Released Lang Actions
POLL RESULTS OF THE 2025 SECOND EXTRAORDINARY GENERAL MEETING
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is an announcement of the poll results of the 2025 Second Extraordinary General Meeting, detailing vote counts, percentages, and confirming that the resolution to appoint an executive director was passed. This matches the definition of "Declaration of Voting Results & Voting Rights Announcements" (DVA).
2025-04-02 English
Monthly Return of Equity Issuer on Movement in Securities for the month ended 31 March 2025
Share Issue/Capital Change Classification · 85% confidence The document is a routine monthly return filed with the Hong Kong Stock Exchange under Chapter 19B of the Listing Rules, detailing movements in authorised, registered, issued and treasury share capital. It is not an earnings release, AGM material, or general regulatory notice but specifically reports on share capital changes. This matches the "Share Issue/Capital Change" category (SHA).
2025-04-02 English
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2024
Earnings Release Classification · 85% confidence The document is titled “Announcement of Annual Results for the year ended 31 December 2024” filed to the Hong Kong Stock Exchange. It contains the consolidated statement of profit or loss, statement of financial position, segment information, basis of preparation and accounting policies – key highlights and audited figures but not the full narrative, governance section or MD&A of a statutory annual report. This aligns with an official earnings/results release rather than a complete annual report (10-K) or merely an RPA. Therefore it should be classified as an Earnings Release. FY 2024
2025-03-28 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2025-03-27 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2025-03-27 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2025-03-27 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.